Supernus' extended-release epilepsy drug wins FDA nod

Supernus Pharmaceuticals obtained FDA approval to market its extended-release epilepsy drug Trokendi XR, a once-daily formulation of topiramate. The firm plans to commercialize the drug in the next few weeks.

View Full Article in:

Drug Store News · Wall Street Journal (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC